首页> 中文期刊> 《中国卫生标准管理》 >探讨丙种球蛋白联合地塞米松治疗小儿急性特发性血小板减少性紫癜的效果

探讨丙种球蛋白联合地塞米松治疗小儿急性特发性血小板减少性紫癜的效果

         

摘要

Objective Analyze the effect of gamma globulin and dexamethasone on children with acute idiopathic thrombocytopenic purpura. MethodsSelect 200 cases of children with acute idiopathic thrombocytopenic purpura, according to the random way in its list of observation group and control group, 100 cases in each group. Control group using dexamethasone, while in the control group on the basis of the observation group treated with ivig.Results Compared two groups of treatment efficient and symptoms of time, the observation group were significantly superior to control group, with significant difference comparing the statistical significance (P<0.05); Two groups had no significant adverse reactions.ConclusionDuring the treatment on children with acute idiopathic thrombocytopenic purpura, gamma globulin and dexamethasone can promote the treatment effect, and it deserves promotion.%目的 分析丙种球蛋白与地塞米松的联合疗法在急性特发性的血小板减少性紫癜患儿治疗中的效果.方法 选取200例急性特发性血小板减少性紫癜患儿,按照随机的方式将其列入观察组与对照组,每组各为100例.对照组使用地塞米松,而观察组则在对照组的基础上使用丙种球蛋白进行治疗.结果 两组治疗有效率和症状缓解时间相比,观察组均要显著优于对照组,比较差异有显著性的统计学的意义(P<0.05);两组均无显著性的不良反应.结论 在小儿急性特发性血小板减少性紫癜的治疗中应用丙种球蛋白与地塞米松的联合疗法可以优化治疗效果.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号